Libya vs Netherlands: New cases tested for RR-/MDR-TB
Libya
91.0%
in 2023
Netherlands
91.0%
in 2024
Libya rank
91st
Netherlands rank
91st
New cases tested for RR-/MDR-TB over time
- Libya
- Netherlands
How they compare
Libya currently reports 91.0% against 91.0% in Netherlands, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2005 it was Netherlands ahead.
Libya ranks 91st and Netherlands ranks 91st of 192 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Libya | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.3% | 100.0% | 99.7% | Netherlands |
| 2010s | 42.0% | 81.0% | 39.0% | Netherlands |
| 2020s | 83.0% | 86.5% | 3.5% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Libya or Netherlands?
- Libya, at 91.0% against 91.0% in Netherlands as of 2023.
- What is the difference in new cases tested for rr-/mdr-tb between Libya and Netherlands?
- 0.0%, with Libya ahead.
- How many years of comparable data are there for Libya and Netherlands?
- 6 years are reported by both, from 2005 to 2021.
- How do Libya and Netherlands rank globally for new cases tested for rr-/mdr-tb?
- Libya ranks 91st and Netherlands ranks 91st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.